Dynamics of cell-free viral burden in HIV-1-infected patients

被引:13
|
作者
Michael, NL
Chang, G
Kim, JH
Birx, DL
机构
[1] WALTER REED ARMY INST RES,DIV RETROVIROL,ROCKVILLE,MD
[2] HENRY M JACKSON FDN,ROCKVILLE,MD
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1997年 / 14卷 / 03期
关键词
viral burden; serum RNA; HIV-1;
D O I
10.1097/00042560-199703010-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Whereas previous cross-sectional studies have shown a 1-2 log increase in cell-free HIV-1 RNA viral burden associated with disease progression, recent longitudinal studies reveal a less dynamic association. We addressed this conundrum in a cohort of 17 rapid and 20 slow progressors. Initial levels of serum viral RNA from the rapid progressors were 1 log unit higher than those from the slow progressors. Serum RNA increased by >0.5 log in 10 of the rapid progressors (increase group), but the remaining seven showed a <0.5 log increase (static group). Patients whose serum RNA increased had lower amounts of serum RNA at study entry but not at follow-up compared with the static group. There was a trend toward lower CD4 counts in the static group at followup. These data suggest that the timing of specimen evaluation can influence interpretation of viral RNA dynamics in HIV disease.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 50 条
  • [41] Viral phenotype affects the thymic production of new T cells in HIV-1-infected children
    Correa, R
    Muñoz-Fernández, A
    AIDS, 2001, 15 (15) : 1959 - 1963
  • [42] The pharmacokinetics of nelfinavir in HIV-1-infected children
    van Heeswijk, RPG
    Scherpbier, HJ
    de Koning, LA
    Heymans, HSA
    Lange, JMA
    Beijnen, JH
    Hoetelmans, RMW
    THERAPEUTIC DRUG MONITORING, 2002, 24 (04) : 487 - 491
  • [43] Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
    Satou, Yorifumi
    Katsuya, Hiroo
    Fukuda, Asami
    Misawa, Naoko
    Ito, Jumpei
    Uchiyama, Yoshikazu
    Miyazato, Paola
    Islam, Saiful
    Fassati, Ariberto
    Melamed, Anat
    Bangham, Charles R. M.
    Koyanagi, Yoshio
    Sato, Kei
    SCIENTIFIC REPORTS, 2017, 7
  • [44] Serial analysis of gene expression in HIV-1-infected T cell lines
    Ryo, A
    Suzuki, Y
    Ichiyama, K
    Wakatsuki, T
    Kondoh, N
    Hada, A
    Yamamoto, M
    Yamamoto, N
    FEBS LETTERS, 1999, 462 (1-2) : 182 - 186
  • [45] Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients
    Vignoli, M
    Stecca, B
    Furlini, G
    Re, MC
    Mantovani, V
    Zauli, G
    Visani, G
    Colangeli, V
    La Placa, M
    AIDS, 1998, 12 (09) : 999 - 1005
  • [46] Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review
    Gianotti, Nicola
    Soria, Alessandro
    Lazzarin, Adriano
    NEW MICROBIOLOGICA, 2007, 30 (02) : 79 - 88
  • [47] Tesamorelin for the treatment of excess abdominal fat in HIV-1-infected patients with lipodystrophy
    Gracia Mateo, Maria
    del Mar Gutierrez, Maria
    Domingo, Pere
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (01) : 21 - 30
  • [48] MYELIN DEGRADING ACTIVITY IN THE CSF OF HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES
    LIUZZI, GM
    MASTROIANNI, CM
    FANELLI, M
    MASSETTI, AP
    VULLO, V
    DELIA, S
    RICCIO, P
    NEUROREPORT, 1994, 6 (01) : 157 - 160
  • [49] Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients
    Vandekerckhove, Linos
    Verhofstede, Chris
    Vogelaers, Dirk
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1087 - 1096
  • [50] The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia
    Ruffini, DD
    Madhi, SA
    AIDS, 2002, 16 (01) : 105 - 112